| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |